Surgical management and postoperative treatment of endometrial carcinoma.
作者： Laurel W Rice , Christopher J Darus , Jason A Lachance
DOI:
关键词:
摘要: Endometrial carcinoma affects over 40,000 American women annually, making it the most common gynecologic malignancy. Over 80% of disease is diagnosed in early stages, resulting a generally favorable prognosis for patients. However, discrepancies still exist with regard to primary surgical management and postoperative adjuvant therapies directed at reducing recurrence rates improving survival. In this review, we outline newly review risk factors that guide clinicians recommendation therapy.
参考文章(49)
Endometrial cancer: what is a clinician to do? Obstetrics & Gynecology. ,vol. 110, pp. 1222- 1223 ,(2007) , 10.1097/01.AOG.0000296093.27006.E5
D M Larson, K Johnson, K A Olson, Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstetrics & Gynecology. ,vol. 79, pp. 998- 1001 ,(1992)
John K. Chan, Renata Urban, Michael K. Cheung, Jacob Y. Shin, Amreen Husain, Nelson N. Teng, Jonathan S. Berek, Joan L. Walker, Daniel S. Kapp, Kathryn Osann, Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer. ,vol. 109, pp. 2454- 2460 ,(2007) , 10.1002/CNCR.22727
William A. Peters, Willie A. Andersen, W.Norman Thornton, George W. Morley, The selective use of vaginal hysterectomy in the management of adenocarcinoma of the endometrium American Journal of Obstetrics and Gynecology. ,vol. 146, pp. 285- 291 ,(1983) , 10.1016/0002-9378(83)90750-0
N LAMBROU, O GOMEZMARIN, R MIRHASHEMI, H BEACH, E SALOM, Z ALMEIDAPARRA, M PENALVER, Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival☆ Gynecologic Oncology. ,vol. 93, pp. 653- 658 ,(2004) , 10.1016/J.YGYNO.2004.03.015
L MADOM, A BROWN, F LUI, R MOORE, C GRANAI, P DISILVESTRO, Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma Gynecologic Oncology. ,vol. 107, pp. 75- 78 ,(2007) , 10.1016/J.YGYNO.2007.05.026
B.M. Slomovitz, L.M. Ramondetta, C.M. Lee, J.C. Oh, P.J. Eifel, A. Jhingran, T.W. Burke, D.M. Gershenson, K.H. Lu, Heterogeneity of stage IIIA endometrial carcinomas: Implications for adjuvant therapy International Journal of Gynecological Cancer. ,vol. 15, pp. 510- 516 ,(2005) , 10.1111/J.1525-1438.2005.15317.X
D. G. Petereit, S. P. Tannehill, E. A. Grosen, E. M. Hartenbach, J. C. Schink, Outpatient vaginal cuff brachytherapy for endometrial cancer International Journal of Gynecological Cancer. ,vol. 9, pp. 456- 462 ,(1999) , 10.1046/J.1525-1438.1999.99061.X
Marcus E. Randall, Kathryn M. Greven, Brachytherapy: criteria for case selection. Cancer Investigation. ,vol. 13, pp. 405- 410 ,(1995) , 10.3109/07357909509031920
Takahide Arimoto, Shunsuke Nakagawa, Toshiharu Yasugi, Hiroyuki Yoshikawa, Kei Kawana, Tetsu Yano, Yuji Taketani, Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma. Gynecologic Oncology. ,vol. 104, pp. 32- 35 ,(2007) , 10.1016/J.YGYNO.2006.07.038